{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:35:25Z","timestamp":1790800525518,"version":"4.1.0"},"reference-count":154,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Heart failure readmissions remain a major challenge for healthcare systems, contributing significantly to morbidity, mortality, and increased healthcare costs. Despite advancements in medical and device-based therapies, rehospitalization rates remain high, particularly within the first 30 days of discharge. This review aims to evaluate the primary factors associated with HF readmissions and discuss evidence-based strategies to reduce these rates. The review examines the efficacy of pharmacological therapies and their impact on readmission rates, highlighting key interventions such as diuretics, beta-blockers, ACE inhibitors, ARBs, ARNIs, SGLT2 inhibitors, and intravenous iron supplementation. Additionally, device-based interventions, including CardioMEMS, LVADs, CRT-P\/D, ICDs, Furoscix, and the ReDS vest, are critically evaluated for their role in the early detection and management of decompensation. Non-pharmacological strategies are also underscored, such as dietary modifications, exercise, cardiac rehabilitation, and structured follow-up programs. By synthesizing current evidence, this review provides a comprehensive analysis of heart failure readmission factors and proposes multidisciplinary, patient-centered strategies to improve outcomes and reduce hospitalizations.<\/jats:p>","DOI":"10.3390\/jcm14165894","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:19:02Z","timestamp":1755789542000},"page":"5894","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Heart Failure Readmission Prevention Strategies\u2014A Comparative Review of Medications, Devices, and Other Interventions"],"prefix":"10.3390","volume":"14","author":[{"given":"Remzi Oguz","family":"Baris","sequence":"first","affiliation":[{"name":"Section of Cardiology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey E.","family":"Tabit","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cardfail.2021.12.017","article-title":"Economic Issues in Heart Failure in the United States","volume":"28","author":"Heidenreich","year":"2022","journal-title":"J. Card. Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ejhf.2103","article-title":"Temporal trends in mortality and readmission after acute heart failure: A systematic review and meta-regression in the past four decades","volume":"23","author":"Kimmoun","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e241420","DOI":"10.1001\/jamanetworkopen.2024.1420","article-title":"Perceived Economic Burden, Mortality, and Health Status in Patients with Heart Failure","volume":"7","author":"Yu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fischer, C., Lingsma, H.F., Marang-van de Mheen, P.J., Kringos, D.S., Klazinga, N.S., and Steyerberg, E.W. (2014). Is the readmission rate a valid quality indicator? A review of the evidence. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112282"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_10","first-page":"e20230825","article-title":"Torsemide versus Furosemide in the Treatment of Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"121","author":"Teixeira","year":"2024","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.064842","article-title":"Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial","volume":"148","author":"Greene","year":"2023","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","article-title":"Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research","volume":"69","author":"Costanzo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: Clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E470","DOI":"10.1532\/hsf.3029","article-title":"The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study","volume":"23","author":"Alshibani","year":"2020","journal-title":"Heart Surg. Forum."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1060028016637385","article-title":"Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure","volume":"50","author":"Woodruff","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_17","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","article-title":"Heart failure","volume":"365","author":"McMurray","year":"2005","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"CIBIS-II Investigators and Committees (1999). The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet, 353, 9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"MERIT-HF Study Group (1999). Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 353, 2001\u20132007.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): Randomised controlled trial","volume":"362","author":"Swedberg","year":"2003","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"82.e1","DOI":"10.1016\/j.ahj.2006.10.008","article-title":"Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ahj.2008.04.030","article-title":"Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"156","author":"Abraham","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jacc.2003.12.040","article-title":"Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: Results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial","volume":"43","author":"Gattis","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.amjmed.2014.11.036","article-title":"Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure","volume":"128","author":"Bhatia","year":"2015","journal-title":"Am. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacc.2012.03.023","article-title":"Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: Results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial","volume":"60","author":"Fiuzat","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cardfail.2023.12.004","article-title":"Improving Guideline-Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction: A Review of Implementation Strategies","volume":"30","author":"Harrington","year":"2024","journal-title":"J. Card. Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0002-9343(98)00385-4","article-title":"Pathophysiology of chronic heart failure","volume":"110","author":"Francis","year":"2001","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Investigators","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"Group","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tai, C., Gan, T., Zou, L., Sun, Y., Zhang, Y., Chen, W., Li, J., Zhang, J., Xu, Y., and Lu, H. (2017). Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: A meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord., 17.","DOI":"10.1186\/s12872-017-0686-z"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global Public Health Burden of Heart Failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card. Fail. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2019.02.043","article-title":"Estimated Long-Term Survival with Eplerenone","volume":"73","author":"Stienen","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: An individual patient level meta-analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-physiol-060821-013950","article-title":"Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases","volume":"84","author":"Bonnard","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2174\/0118715303350851241021105850","article-title":"Improving Renal Protection in Chronic Kidney Disease Associated with Type 2 Diabetes: The Role of Finerenone","volume":"25","author":"Nugroho","year":"2025","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100076","DOI":"10.1016\/j.shj.2022.100076","article-title":"From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion","volume":"6","author":"Dahiya","year":"2022","journal-title":"Struct. Heart"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ehjcvp\/pvae083","article-title":"Subcutaneous furosemide in heart failure: A systematic review","volume":"11","author":"Osmanska","year":"2025","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jchf.2024.07.015","article-title":"Avoiding Treatment in Hospital with Subcutaneous Furosemide for Worsening Heart Failure: A Pilot Study (AT HOME-HF)","volume":"12","author":"Konstam","year":"2024","journal-title":"JACC Heart Fail."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic Treatment in Heart Failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/heartjnl-2014-305669","article-title":"Iron deficiency: An emerging therapeutic target in heart failure","volume":"100","author":"Leclercq","year":"2014","journal-title":"Heart"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: A multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.amjcard.2021.04.042","article-title":"Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease with and without Heart Failure","volume":"152","author":"Ambrosy","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"D3","DOI":"10.1093\/eurheartj\/suaa090","article-title":"Short-term treatments for acute cardiac care: Inotropes and inodilators","volume":"22","author":"Guarracino","year":"2020","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101245","DOI":"10.1016\/j.cpcardiol.2022.101245","article-title":"Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock","volume":"48","author":"Biswas","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCHEARTFAILURE.115.002259","article-title":"Tolvaptan in Patients Hospitalized with Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials","volume":"8","author":"Felker","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am. Heart J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1096.e1","DOI":"10.1016\/j.ahj.2006.08.003","article-title":"Chronic inotropic therapy in end-stage heart failure","volume":"152","author":"Hauptman","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.2147\/IJGM.S436999","article-title":"Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial","volume":"16","author":"He","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Li, M., Wang, Y., Qi, Z., Yuan, Z., Lv, S., Zheng, Y., Yan, Z., Wang, M., Fu, H., and Fan, X. (2022). QishenYiqi dripping pill protects against myocardial ischemia\/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.981206"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Anwaier, G., Xie, T.T., Pan, C.S., Li, A.Q., Yan, L., Wang, D., Chen, F.K., Weng, D.Z., Sun, K., and Chang, X. (2022). QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19\/TGF-beta1 Signaling Pathway. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.918335"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Chen, W., Chen, J., Wang, Y., Yan, J., Yan, X., Wang, D., and Liu, Y. (2022). The role of Qishen Yiqi dripping pills in treating chronic heart failure: An overview of systematic reviews and meta-analyses. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.1001072"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/ejhf.2015","article-title":"Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials","volume":"22","author":"Teerlink","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000541393","article-title":"Efficacy of Modern Therapies for Heart Failure with Reduced Ejection Fraction in Specific Population Subgroups: A Systematic Review and Network Meta-Analysis","volume":"14","author":"Lavalle","year":"2024","journal-title":"Cardiorenal Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.hrtlng.2015.12.001","article-title":"A systematic review of transitional-care strategies to reduce rehospitalization in patients with heart failure","volume":"45","author":"Albert","year":"2016","journal-title":"Heart Lung."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure","volume":"303","author":"Hernandez","year":"2010","journal-title":"JAMA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.2012.216476","article-title":"Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia","volume":"309","author":"Dharmarajan","year":"2013","journal-title":"JAMA"},{"key":"ref_83","unstructured":"John, M., and Eisenberg Center for Clinical Decisions and Communications Science (2007). Transitional Care Interventions to Prevent Read-missions for People with Heart Failure, Comparative Effectiveness Review Summary Guides for Clinicians."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMp1901225","article-title":"The Hospital Readmissions Reduction Program\u2014Time for a Reboot","volume":"380","author":"Wadhera","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCOUTCOMES.111.000101","article-title":"Hospital strategies associated with 30-day readmission rates for patients with heart failure","volume":"6","author":"Bradley","year":"2013","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/M14-0083","article-title":"Transitional care interventions to prevent readmissions for persons with heart failure: A systematic review and meta-analysis","volume":"160","author":"Feltner","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.0000151811.53450.B8","article-title":"Discharge education improves clinical outcomes in patients with chronic heart failure","volume":"111","author":"Koelling","year":"2005","journal-title":"Circulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bmj.39156.536968.55","article-title":"Telemonitoring or structured telephone support programmes for patients with chronic heart failure: Systematic review and meta-analysis","volume":"334","author":"Clark","year":"2007","journal-title":"BMJ"},{"key":"ref_89","first-page":"CD007228","article-title":"Structured telephone support or telemonitoring programmes for patients with chronic heart failure","volume":"8","author":"Inglis","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_90","first-page":"810","article-title":"Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials","volume":"44","author":"McAlister","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2105\/AJPH.2015.302987","article-title":"Effects of Community-Based Health Worker Interventions to Improve Chronic Disease Management and Care Among Vulnerable Populations: A Systematic Review","volume":"106","author":"Kim","year":"2016","journal-title":"Am. J. Public Health"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/HPC.0000000000000220","article-title":"Community Health Workers Reduce Rehospitalizations and Emergency Department Visits for Low-Socioeconomic Urban Patients with Heart Failure","volume":"19","author":"Vohra","year":"2020","journal-title":"Crit. Pathw. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e002550","DOI":"10.1136\/bmjgh-2020-002550","article-title":"Prioritising the role of community health workers in the COVID-19 response","volume":"5","author":"Ballard","year":"2020","journal-title":"BMJ Glob. Health"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/ijnmr.ijnmr_123_21","article-title":"Effect of Home Care Program on Re-hospitalization in Advanced Heart Failure: A Clinical Trial","volume":"27","author":"Shabani","year":"2022","journal-title":"Iran. J. Nurs. Midwifery Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jchf.2020.06.009","article-title":"Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations","volume":"8","author":"Sterling","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_97","unstructured":"National Bureau Economic Research (2015). Medical Spending of the Elderly. The Bulletin on Retirement and Disability (BRD) and the Bulletin on Health, National Bureau Economic Research."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e2222056","DOI":"10.1001\/jamanetworkopen.2022.22056","article-title":"Association of Early Physician Follow-up with Readmission Among Patients Hospitalized for Acute Myocardial Infarction, Congestive Heart Failure, or Chronic Obstructive Pulmonary Disease","volume":"5","author":"Saxena","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1112.e17","DOI":"10.1016\/j.amjmed.2017.03.044","article-title":"Cardiology Consultation in the Emergency Department Reduces Re-hospitalizations for Low-Socioeconomic Patients with Acute Decompensated Heart Failure","volume":"130","author":"Tabit","year":"2017","journal-title":"Am. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ajem.2017.12.012","article-title":"A clinical pathway for heart failure reduces admissions from the ED without increasing congestion in the ED","volume":"36","author":"Spiegel","year":"2018","journal-title":"Am. J. Emerg. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jchf.2023.04.015","article-title":"Opportunities and Achievement of Medication Initiation Among Inpatients with Heart Failure with Reduced Ejection Fraction","volume":"11","author":"Swat","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e006168","DOI":"10.1161\/CIRCOUTCOMES.119.006168","article-title":"Systemizing the Evaluation of Acute Heart Failure in the Emergency Department: A Quality Improvement Initiative","volume":"13","author":"Hejjaji","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/ejhf.2888","article-title":"Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC","volume":"25","author":"Metra","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2024.11.019","article-title":"The relationship of diuretics and dietary sodium in patients with heart failure: An analysis of the SODIUM-HF trial","volume":"281","author":"Zhou","year":"2025","journal-title":"Am. Heart J."},{"key":"ref_105","first-page":"e009879","article-title":"Sodium Restriction in Patients with Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"16","author":"Sepehrvand","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2009.08.012","article-title":"Micronutrient deficiencies an unmet need in heart failure","volume":"54","author":"Soukoulis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jchf.2017.09.020","article-title":"Adherence to Mediterranean Diet and All-Cause Mortality After an Episode of Acute Heart Failure: Results of the MEDIT-AHF Study","volume":"6","author":"Miro","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"Whellan","year":"2009","journal-title":"JAMA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1161\/01.CIR.98.24.2709","article-title":"Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure","volume":"98","author":"Hambrecht","year":"1998","journal-title":"Circulation"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjmed.2003.11.033","article-title":"Exercise training for patients with heart failure: A systematic review of factors that improve mortality and morbidity","volume":"116","author":"Smart","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_111","first-page":"CD003331","article-title":"Exercise-based rehabilitation for heart failure","volume":"2014","author":"Taylor","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2021.01.030","article-title":"Cardiac Rehabilitation for Patients with Heart Failure: JACC Expert Panel","volume":"77","author":"Bozkurt","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIR.0000000000000663","article-title":"Home-Based Cardiac Rehabilitation: A Scientific Statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology","volume":"140","author":"Thomas","year":"2019","journal-title":"Circulation"},{"key":"ref_114","first-page":"CD003331","article-title":"Exercise-based cardiac rehabilitation for adults with heart failure","volume":"1","author":"Long","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11886-016-0799-5","article-title":"Psychological Aspects of Heart Failure","volume":"18","author":"Moser","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2017.02.120","article-title":"Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations","volume":"240","author":"Amir","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jchf.2016.12.011","article-title":"A Multisensor Algorithm Predicts Heart Failure Events in Patients with Implanted Devices: Results from the MultiSENSE Study","volume":"5","author":"Boehmer","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jchf.2024.01.002","article-title":"Remote Dielectric Sensing Before and After Discharge in Patients with ADHF: The ReDS-SAFE HF Trial","volume":"12","author":"Lala","year":"2024","journal-title":"JACC Heart Fail."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/ehf2.14690","article-title":"Prognostic impact of residual pulmonary congestion assessed by remote dielectric sensing system in patients admitted for heart failure","volume":"11","author":"Izumida","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/ehf2.14698","article-title":"Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: A cost-benefit analysis","volume":"11","author":"Codina","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2017.03.009","article-title":"Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in \u201cReal-World\u201d Clinical Practice","volume":"69","author":"Desai","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e006863","DOI":"10.1161\/CIRCHEARTFAILURE.119.006863","article-title":"Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes from the CardioMEMS Post-Approval Study","volume":"13","author":"Shavelle","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/clc.22696","article-title":"Cost-Effectiveness of Remote Cardiac Monitoring with the CardioMEMS Heart Failure System","volume":"40","author":"Schmier","year":"2017","journal-title":"Clin. Cardiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: Complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","article-title":"Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: Results from the REPLACE registry","volume":"122","author":"Poole","year":"2010","journal-title":"Circulation"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2015.05.135","article-title":"Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management","volume":"195","author":"Brouwer","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.hrthm.2019.01.033","article-title":"Predicting defibrillator benefit in patients with cardiac resynchronization therapy: A competing risk study","volume":"16","author":"Weber","year":"2019","journal-title":"Heart Rhythm"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pcad.2021.04.003","article-title":"Cardiac resynchronization therapy using a pacemaker or a defibrillator: Patient selection and evidence to support it","volume":"66","author":"Canterbury","year":"2021","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/eurheartj\/ehac053","article-title":"Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: The RESET-CRT project","volume":"43","author":"Hadwiger","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e004669","DOI":"10.1161\/CIRCHEARTFAILURE.117.004669","article-title":"HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results from the MultiSENSE Study","volume":"11","author":"Gardner","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.healun.2022.02.005","article-title":"Evaluation of a novel virtual care platform for remote monitoring of LVAD patients","volume":"41","author":"Patel","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.gie.2014.03.040","article-title":"GI bleeding in patients with continuous-flow left ventricular assist devices: A systematic review and meta-analysis","volume":"80","author":"Draper","year":"2014","journal-title":"Gastrointest. Endosc."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/healthcare3030750","article-title":"The Importance of the Management of Infectious Complications for Patients with Left Ventricular Assist Device","volume":"3","author":"Hieda","year":"2015","journal-title":"Healthcare"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","article-title":"Elevated Angiopoietin-2 Level in Patients with Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated with Higher Nonsurgical Bleeding","volume":"134","author":"Tabit","year":"2016","journal-title":"Circulation"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.healun.2017.06.001","article-title":"Tumor necrosis factor-alpha levels and non-surgical bleeding in continuous-flow left ventricular assist devices","volume":"37","author":"Tabit","year":"2018","journal-title":"J. Heart Lung Transpl."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","article-title":"The Society of Thoracic Surgeons Intermacs 2020 Annual Report","volume":"111","author":"Molina","year":"2021","journal-title":"Ann. Thorac. Surg."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bpa.2012.03.006","article-title":"Right ventricular failure after LVAD implantation: Prevention and treatment","volume":"26","author":"Meineri","year":"2012","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJMoa1800866","article-title":"Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure","volume":"378","author":"Mehra","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamainternmed.2013.3023","article-title":"Potentially avoidable 30-day hospital readmissions in medical patients: Derivation and validation of a prediction model","volume":"173","author":"Donze","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/jamainternmed.2015.8462","article-title":"International Validity of the HOSPITAL Score to Predict 30-Day Potentially Avoidable Hospital Readmissions","volume":"176","author":"Donze","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/bmjebm-2019-111271","article-title":"HOSPITAL Score, LACE Index and LACE+ Index as predictors of 30-day readmission in patients with heart failure","volume":"25","author":"Ibrahim","year":"2020","journal-title":"BMJ Evid. Based Med."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Obuobi, S., Chua, R.F.M., Besser, S.A., and Tabit, C.E. (2021). Social determinants of health and hospital readmissions: Can the HOSPITAL risk score be improved by the inclusion of social factors?. BMC Health Serv. Res., 21.","DOI":"10.1186\/s12913-020-05989-7"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Rajaguru, V., Han, W., Kim, T.H., Shin, J., and Lee, S.G. (2022). LACE Index to Predict the High Risk of 30-Day Readmission: A Systematic Review and Meta-Analysis. J. Pers. Med., 12.","DOI":"10.3390\/jpm12040545"},{"key":"ref_149","first-page":"e80","article-title":"LACE+ index: Extension of a validated index to predict early death or urgent readmission after hospital discharge using administrative data","volume":"6","author":"Wong","year":"2012","journal-title":"Open Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJGM.S150676","article-title":"Determining 30-day readmission risk for heart failure patients: The Readmission After Heart Failure scale","volume":"11","author":"Chamberlain","year":"2018","journal-title":"Int. J. Gen. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11845-021-02519-0","article-title":"An assessment of race and gender-based biases among readmission predicting tools (HOSPITAL, LACE, and RAHF) in heart failure population","volume":"191","author":"Regmi","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cjco.2024.11.006","article-title":"Guideline-Referral Criteria and Risk Profiles of Outpatients Referred to a Specialised Heart Failure Clinic","volume":"7","author":"Tan","year":"2025","journal-title":"CJC Open"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/CIR.0b013e31824f2173","article-title":"Decision making in advanced heart failure: A scientific statement from the American Heart Association","volume":"125","author":"Allen","year":"2012","journal-title":"Circulation"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCHEARTFAILURE.116.003032","article-title":"INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure","volume":"9","author":"Stewart","year":"2016","journal-title":"Circ. Heart Fail."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5894\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:33Z","timestamp":1760034753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":154,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165894"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165894","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}